PEMGARDA™ (pemivibart) net product revenue of $13.8 million, representing 48% growth over Q3 2024 net product revenue of $9.3 ...
AI-enhanced glucose monitoring provides predictive analytics and personalized insights for better blood sugar management.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback